Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Warner Chilcott ( WCRX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.4%. By the end of trading, Warner Chilcott fell $0.22 (-1.0%) to $21.22 on average volume. Throughout the day, 3,352,017 shares of Warner Chilcott exchanged hands as compared to its average daily volume of 3,824,200 shares. The stock ranged in price between $21.06-$21.57 after having opened the day at $21.57 as compared to the previous trading day's close of $21.44. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 42.7%, Chemocentryx ( CCXI), down 28.8%, Ambit Biosciences ( AMBI), down 10.4% and Biostar Pharmaceuticals ( BSPM), down 9.1%.

Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women's healthcare, gastroenterology, urology, and dermatology markets. Warner Chilcott has a market cap of $5.3 billion and is part of the drugs industry. Shares are down 2.1% year to date as of the close of trading on Thursday. Currently there are 5 analysts that rate Warner Chilcott a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Warner Chilcott as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that revenues have generally been declining.

On the positive front, Sunshine Heart ( SSH), up 21.0%, GW Pharmaceuticals PLC ADR ( GWPH), up 17.9%, Prana Biotechnology ( PRAN), up 17.5% and Escalon Medical Corporation ( ESMC), up 17.5% , were all gainers within the health care sector with Questcor Pharmaceuticals ( QCOR) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.